As the acute morbidity and mortality of coronary artery bypass graft (CABG) surgery progressively declines, long-term outcomes have become an increasingly more important consideration in decisions regarding revascularization. While patients undergoing CABG are generally thought to require fewer repeat revascularization procedures than those receiving percutaneous coronary intervention (PCI), information on contemporary rates of repeat revascularization following CABG is sparse. Although most previous studies have demonstrated finite longevity of saphenous vein grafts, 1, 2 there have been modern improvements in conduit harvesting techniques, greater use of arterial grafts (which have higher long-term patency), and secondary prevention-all of which may reduce the need for repeat revascularization.
Conversely, the ability to treat saphenous vein graft disease using percutaneous interventional techniques has also evolved, which may have prompted more interventions over time.
There is currently limited information on contemporary rates of repeat revascularization following CABG surgery, and there is a clear need to establish national benchmarks for reference. Having access to this information is particularly important given that studies comparing CABG to PCI often examine revascularization rates. Using linked data from the Society of Thoracic Surgeons (STS) National Adult Cardiac Surgery Database and the Centers for Medicare & Medicaid Services (CMS), we sought to: (1) determine long-term rates of repeat coronary revascularization (PCI and reoperative CABG) after initial CABG; (2) describe temporal trends in repeat revascularization; (3) identify patient-level factors associated with early and late repeat revascularization; and (4) determine whether these rates vary among hospital providers.
Conversely, the ability to treat saphenous vein graft disease using percutaneous i in nt nter er e ve ve ent nt ntio io iona na n l l echniques has also evolved, which may have prompted more interventions over time.
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Methods
Data Sources/Study Population Data Sources and Linkages
We identified isolated CABG procedures from the STS database (which includes detailed clinical information), and linked these records to Medicare Part A claims data from CMS.
Though the STS database is limited to short-term follow-up, we have previously shown that STS data can be linked with CMS claims data to obtain longitudinal, long-term follow-up.
3
Study Patients
We identified all patients in STS who underwent isolated CABG at STS-participating sites and who were discharged between January 1, 1991 and December 31, 2007; therefore, 18 years of outcomes data are available for this cohort. Patients were excluded from the cohort if they had a concomitant valve procedure or other cardiac procedure (other than the placement of pacemaker or ablation procedure for atrial fibrillation) or if the CABG status was emergent or salvage.
Patients who underwent previous CABG (as defined in the STS database) were likewise excluded, but we included patients who had a prior PCI. We included only patients enrolled in fee-for-service Medicare parts A and B (Figure 1 ).
A subset of CABG patients who underwent surgery between 2001 and 2003 was used to
analyze contemporary factors associated with 1 year and 1 to 5 year rates of repeat revascularization ( Table 1) .
Outcomes
The primary outcome for this study was repeat revascularization, identified as either CABG or a a ab blation proc oced ed e ur ure e fo for r r at at atri ri ial al al fi fibr br bril il illa lat tio o on) o or or if th h he e CA A ABG BG BG st t tat atu u us w was as e em me merg rg rge en ent t or or or s s sal al lv va vag ge ge. .
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Mortality was obtained through the Medicare beneficiary summary file and was available for analyses.
Covariates
In addition to the covariates used in prior CABG risk models, repeat revascularization might also be associated with partial revascularization during the index procedure. As a crude proxy for the latter, which is not specifically documented in the STS database, we created a covariate for anatomical revascularization completeness by subtracting the number of diseased vessels found preoperatively from the number of grafts placed, and categorized into the following groups: <0, 0, 1-2, and >2. To examine variation in repeat revascularization across sites, we selected all centers with more than 100 CABG cases per year in the database from 2001-2003.
Statistical Analysis
To identify statistical differences between groups, we used the Kruskal-Wallis test for continuous variables and 2 tests for categorical variables. Longitudinal non-fatal outcomes after CABG were described using the cumulative incidence function and also by the Kaplan-Meier estimator, censoring patients at the time of death for sensitivity purposes. Similarly, we performed analyses for mortality in order to assess the degree of competing risk by death. For each surgical year, the revascularization rate at the end of the first year of follow-up was estimated by Kaplan-Meier estimator to show temporal trends in revascularization after CABG.
Comparative temporal trends were also summarized using an averaged hazard ratio for revascularization over the first year following CABG, with year 1999 as the reference. 
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Results
A total of 723,134 patients undergoing first-time isolated CABG between 1991 and 2007 were included in this study after applying inclusion/exclusion criteria (Figure 1) . Overall, 15.4% of patients were excluded due to prior CABG or emergent/salvage status and an additional 26.9%
were excluded because of unsuccessful linkage or Medicare Part A eligibility only. Baseline year, with maximal 4-year follow-up (i.e., censoring alive, event-free patients at t t t the he e end nd nd o o of f f 4-4 4-years of follow-up). The second Cox regression is comparable to a landmark analysis.
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Discussion
Our study examined repeat revascularization among older Medicare adults who had undergone CABG. We had four major findings. First, repeat revascularization rates after CABG in older individuals are generally low and are almost always PCI, with very low rates of repeat CABG.
Second, the overall rates of repeat revascularization after CABG have risen slightly over time, Historically, the need for repeat revascularization after CABG was driven both by the progression of native vessel disease and by relatively low rates of vein graft patentcy.
1,7-10
Clinical registry and trials data have shown a repeat revascularization rate of about 5% at 5 years post-surgery, 10 but these prior studies were limited in size, types of centers, and duration of follow-up. 1, 7, 8, 10, 11 Over an 18-year time frame, our study was able to document a low rate of repeat revascularization after CABG among patients aged 65 years and older. Less than 10% of CABG patients required a repeat revascularization procedure within 5 years, 13% within 10 years, and only one in six patients who survive 18 years underwent a repeat procedure. By 10 years, this rate is only approximately 13%. By 18 years, less than one in 25 will require a repeat CABG procedure. The observed lower rate of repeat revascularization may reflect differences in the rate of progression of atherosclerosis in the elderly, higher contemporary usage of arterial grafting for CABG, and the near universal use of statin drugs, which have mitigated the development of both native vessel and vein graft disease. Importantly, we were only able to study patients over the age of 65 years; therefore, rates of repeat revascularization could be substantially higher in younger post-CABG patients. Supporting that hypothesis, we did see a substantial decline in repeat revascularization rates as a function of age, and rates of repeat CABG were also higher among the youngest group of patients. For patients older than 70 years, the need for repeat revascularization is minimal. In contrast, our results suggest that among CABG patients aged 65-69 years, almost one-third will be revascularized at least one more time epeat revascularization after CABG among patients aged 65 years and older. Les es ss th th t an an an 1 1 10% 0% 0% o of CABG patients required a repeat revascularization procedure within 5 years, 13% within 10 ye year ar ars, s, s, a a and nd nd o o onl nl n y on on one e e in six patients who survive 18 18 18 y y years underwe ent n n a r rep ep epea e t procedure. By 10 y year r ars, s this rate e i i is s s o o only ly app pp ppro ro roxi xi xim ma mate te tely ly ly 1 1 13 3% %. By By By 18 8 y ye ear r rs, s, , l les es ss th tha an n o one ne i i in 25 25 w w wil ill l re re requ qu quir i ire e a a a re repe pe peat CA CA ABG BG BG p p pro ro oce ce cedu dur re e. Th The e o ob obs serv rv ved ed ed l l low ow ower er r r rat at ate e e of of f r r rep ep pea a at t r re reva va vasc sc scul ul lar ar a iz iz zat at atio io ion n m ma may y re re r fl fl f ec ec ct t t d d diff ff fer r ren enc ce es s in in he rate of pr prog og ogre re r ss ss ssio io ion n n of o o a a ath th ther e e os os oscl cl c er er eros os sis is i i i in n n th th the e el el lde de d rl rl r y, y, h h hig ig ghe he her r r co co cont t tem em empo po pora ra rary ry r u u usa sa sage ge ge o o of f arterial during the subsequent 18 years. Nevertheless, among those 65-69 years, the rate of repeat CABG remained under 5% during this long term follow-up. Our results also show that revascularization rates have varied over time. Repeat CABG rates have been steadily declining from 1991 to 2007, though the absolute changes are small. Conversely, the use of PCI steadily increased from 1991 to 2004, after which it declined for unclear reasons.
Numerous factors were associated with short-and long-term repeat revascularization.
Age, left main disease, smoking, and complete revascularization were associated with lower short-and long-term revascularization rates, whereas female gender, cardiovascular risk factors, left ventricular ejection fraction, unstable angina, and dialysis were associated with higher rates of repeat revascularization. Interestingly, the association between body mass index and repeat revascularization rates completely reversed over time. Obese patients had lower rates of repeat revascularization at 1 year relative to those with normal body mass index at surgery; however, between 1 and 5 years, the obese patients had a higher likelihood of being revascularized compared with those who had a normal weight at the time of their initial surgery.
Prior studies have shown that standard cardiovascular risk factors are closely related to subsequent CABG graft failure. 2, [12] [13] [14] [15] Our results suggest further opportunities for identifying categories of patients with higher odds of requiring repeat revascularization, due to graft failure or progression of native vessel disease (Supplemental Figure 1) .
Our study showed two-fold variation between centers for repeat revascularization with 10, 90 percentiles of 1.1% and 5.1% at 1 year and 5.1% and 14.5% from 1 to 5 years postsurgery. Rates of repeat revascularization are a potential measure of hospital performance after CABG, and the variability in these rates across STS sites in the current study lends support to this strategy.
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Limitations
Our study has several limitations. First, the STS database gathers information from a large sample of hospitals in the United States, but the registry is voluntary. Nevertheless, the STS database now encompasses about 95% of all United States cardiac surgery programs, and results derived from it should at least be generalizable within this country. This being said, our selection criteria excluded a substantial number of CABG patients in order to create a homogenous and meaningful cohort; therefore, interpretation of the present study is only applicable to the selected cohort, and consequent extrapolation should be done cautiously. Second, this study was limited to patients aged 65 and older who could be followed through Medicare part A claims files;
therefore, we cannot necessarily extrapolate our results regarding repeat revascularization following CABG to younger patients. However, given that the median age of isolated CABG patients in the United States was 65 years (IQR 58-73) in 2011, our study population should be quite representative. 16 Third, we did not have any information regarding the indication for repeat revascularization, nor about subsequent studies such as stress testing and echocardiography.
Fourth, our models used repeat revascularization as the outcome, and death will be a natural competing outcome for this nonfatal event. We analyzed the data using cause-specific Cox proportional hazard models and censored patients at death, acknowledging that this may result in an underestimation of repeat revascularization rates. In addition, cumulative incidence rates were also reported for revascularization and these results are methodologically influenced by mortality; revascularization rates are naturally low if mortality is high and the measure represents the actual observed rate in the baseline cohort. Finally, all observed results for our metric of revascularization completeness should be interpreted cautiously. Our findings are interesting and should be further examined in a database with further angiographic detail.
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Conclusions
The rate of repeat revascularization after CABG in older individuals is low during nearly two decades of follow-up, and the vast majority of procedures during this time are PCIs. Repeat revascularization rates have increased slightly over time, but remain low-approximately 2-3% of patients will be revascularized annually. Important factors associated with higher rates of repeat revascularization at 1 and 5 years post-surgery included younger age and female sex, traditional cardiovascular risk factors for atherosclerosis, and incomplete revascularization. We observed modest variation in rates of repeat revascularization among centers in the STS database. The information provided in this report provides national benchmarks that should be useful in future studies dealing with revascularization. CABG indicates coronary artery bypass graft surgery; PCI, percutaneous coronary intervention
Death or revascularization rate Kaplan-Meier probability (%)
